Biodefence and the production of knowledge: rethinking the problem

Biodefence, broadly understood as efforts to prevent or mitigate the damage of a bioterrorist attack, raises a number of ethical issues, from the allocation of scarce biomedical research and public health funds, to the use of coercion in quarantine and other containment measures in the event of an o...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical ethics Vol. 39; no. 4; pp. 195 - 204
Main Authors Buchanan, Allen, Kelley, Maureen C
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and Institute of Medical Ethics 01.04.2013
BMJ Publishing Group
BMJ Publishing Group Ltd
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biodefence, broadly understood as efforts to prevent or mitigate the damage of a bioterrorist attack, raises a number of ethical issues, from the allocation of scarce biomedical research and public health funds, to the use of coercion in quarantine and other containment measures in the event of an outbreak. In response to the US bioterrorist attacks following September 11, significant US policy decisions were made to spur scientific enquiry in the name of biodefence. These decisions led to a number of critical institutional changes within the US federal government agencies governing scientific research. Subsequent science policy discussions have focused largely on ‘the dual use problem’: how to preserve the openness of scientific research while preventing research undertaken for the prevention or mitigation of biological threats from third parties. We join others in shifting the ethical debate over biodefence away from a simple framing of the problem as one of dual use, by demonstrating how a dual use framing distorts the debate about bioterrorism and truncates discussion of the moral issues. We offer an alternative framing rooted in social epistemology and institutional design theory, arguing that the ethical and policy debates regarding ‘dual use’ biomedical research ought to be reframed as a larger optimisation problem across a plurality of values including, among others: (1) the production of scientific knowledge; (2) the protection of human and animal subjects; (3) the promotion and protection of public health (national and global); (4) freedom of scientific enquiry; and (5) the constraint of government power.
Bibliography:Related-article-href:10.1136/medethics-2012-100545
local:medethics;39/4/195
ark:/67375/NVC-D23MX52H-5
istex:44936E70FAD2E64D252DFEBB51A8FAA3E94A11BD
href:medethics-39-195.pdf
PMID:22194319
ArticleID:medethics-2011-100387
related-article-ID:RA1
Related-article-href:10.1136/medethics-2012-100526
Related-article-href:10.1136/medethics-2012-100923
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0306-6800
1473-4257
1473-4257
DOI:10.1136/medethics-2011-100387